OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-12-31-accounts

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

Charity Number: 1176307

The ecancer Global Foundation FINANCIAL STATEMENTS For the Year Ended 31 December 2020

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

C O N T E N T S
Page
LEGAL AND ADMINISTRATIVE DETAILS 1
TRUSTEES’ REPORT 2 - 5
AUDITOR’S REPORT 6-8
STATEMENT OF FINANCIAL ACTIVITIES 9
BALANCE SHEET 10
STATEMENT OF CASH FLOWS 11
NOTES TO THE FINANCIAL STATEMENTS
12-16

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

Principal address The ecancer Global Foundation 13 King Square Avenue Bristol BS2 8HU Auditors Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Trustees:

The trustees who served during the year were: Emily Sarah Kobbe Penelope Jane Crocker Professor Richard Sullivan James Isola

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The e cancer Global Foundation TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2020

Message from the chair

2020 has been an incredibly challenging year globally with the true impact felt by cancer patients and professionals for years to come. There are elements of how we work as a society that may never return to pre-covid times and ecancer has had to adjust to these changes as has everyone.

Prof Richard Sullivan

One of the key changes that has impacted ecancer is an enhanced recognition of the importance of online education. As such, ecancer has had a hugely successful year in 2020 with a 57% increase in learners engaging with our educational resources and sustained with a 10% increase in funding.

The growth in engagement is also supported by changes to our editorial policies. During 2020 we took the important step of amending the submission criteria for our journal, ecancermedicalscience, in order to support authors and the research community in Low- and Middle- Income Countries (LMICs).

This vital step ensures that we can concentrate our resources where they are needed most and will go some way towards addressing the current imbalance in global research and publishing. It has also resulted in a significant increase in interest and engagement with the global research community who recognise the importance of this initiative with an 104% increase in submissions and 60% more publications compared to 2019.

The covid pandemic has impacted the different areas of our work in varying ways. We have had to adapt and also been flexible enough to face the challenges but also respond to the opportunities. As such, our Events Team have been focusing on delivering virtual congresses and our Video and e-learning Teams have been creating resources online rather that face-to-face. These changes have allowed us to create high-quality resources with impressive engagement with our learners throughout the pandemic. As the world returns to a level of normality, we will be focusing on incorporating any improvements into our work practices from now on.

As always, we are hugely appreciative to all of the individuals and organisations who we work with to improve care for cancer patients across the world. The global cancer community will face many challenges over the coming years but ecancer will do everything we can to support everyone involved by continuing to provide highquality, accessible education.

Prof Richard Sullivan – Chair of Trustees

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The e cancer Global Foundation TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2020

Report of the Trustees

The Trustees hereby present the statutory report, with the accounts of The ecancer Global Foundation, for the year ending 31 December 2020.

The results for the year are presented in the form of a Statement of Financial Activities, which incorporates the traditional income and expenditure account, in order to comply with the Statement of Recommended Practice for Charities, and in accordance with the Charities Act 2011.

The Trust

The accounts accompanying this report are the accounts of the charitable trust. It is registered with the Charities Commission, Charity Registration number 1176307.

Charitable objectives

Our vision

A world in which every cancer patient receives the best possible care and treatment.

Our mission and future plans

e cancer's mission is to raise the standards of care for cancer patients across the world through education. Throughout the next 12 months, the charity will focus on managing the post Brexit process, as well as managing the transition to a post COVID world. The charity also aims to build on the success of 2020 and to increase the levels of income while effectively managing expenditure.

Another key future plan for the charity is to recruit the first Individual Giving Fundraiser and develop a comprehensive fundraising strategy.

Public benefit statement:

The ecancer Global Foundation’s charitable purpose is carried out for the public benefit in accordance with our vision and mission. The Trustees confirm that they have complied with the duty in Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s general guidance on Charities and Public Benefit.

Educational activities for healthcare professionals

The majority of the oncology professionals who engage with our educational resources do so through our open access and free website, ecancer.org. The site provides a vast knowledge bank covering every cancer type which are developed in partnership with leading global experts to meet regional educational needs. ecancer.org has been publishing free education for the oncology community since 2007 and, as such, has an established audience from around the world.

As well as ecancer.org, our ethos is to provide educational resources to the global oncology community wherever there is a need to as wide an online audience as possible. Our resources are therefore also disseminated through platforms such as YouTube, PubMed, Twitter, Facebook, LinkedIn, Scopus, Web of Science, Embase, EBSCO and Google Scholar as well as other educational partners such as the Union for International Cancer Control (UICC), the International Cancer Control Partnership and the International Society for Geriatric Oncology (SIOG).

A section of ecancer.org is dedicated to healthcare professionals in Latin America with content in predominantly in Spanish but also in Portuguese. We have native Spanish speakers who manage and maintain this section with support from our other team members.

We also publish ecancerpatient.org which is a patient-focused website that provides the latest cancer information direct from experts in an easy-to-understand format that was developed in partnership with patient groups. The goal is to empower patients to be more involved in the decision-making process when it comes to their care.

Our series of educational events in under-served areas of the world is now well established in Latin America and has launched in India with fantastic educational partners allowing us to deliver high quality education in areas of the world that need it most.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

Key 2020 highlights (figures in brackets show change from 2019) ecancer.org

Video

Journal (ecancermedicalscience)

e-learning

News

Research projects

Events

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

Trustee Recruitment and training programme

The existing Trustees and CEO review any gaps in the group of Trustees on an ongoing basis, and if there is a shortage, will review suitable individuals who fit the requirements profile. Any individual is then approached and recruited, and follows the charity’s training and induction process.

Pay and remuneration is reviewed on an annual basis as part of the budgeting process, and is agreed at Trustee level.

Decision making

The charity is managed by the CEO, with support from the Senior Management Team. Key decisions likely to significantly impact the organisation are agreed by the CEO and Trustees, who review and evaluate in detail.

Risk Assessment

In accordance with the SORP requirements, the Trustees carry out wide-ranging reviews of the risks faced by the charity. These reviews look particularly at Health and Safety issues, management and financial accountability and internal security. The Trustees are satisfied that all appropriate and feasible measures have been put in place to reduce the risks to which the charity is exposed. As a consequence of this, the Trustees have greater awareness of the kinds of risks which could affect the charity and have implemented strategies to reduce such risks.

Reserves policy and financial position

As a young charity, we are currently in the process of building reserves to achieve the aims of the organisation which is to maintain free unrestricted reserves:

The e cancer Global Foundation Trustees agreed to a target of unrestricted reserves of £150,000 by the end of 2020.

STATEMENT OF TRUSTEES’ RESPONSIBILITIES

The Trustees of the Charity are required to prepare for each financial year accounts which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources of the Charity for that period. In preparing those financial statements, the trustees are required to:

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust Deed dated 5 June 1956. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 18/10/2021

Approved by the Trustees on ……………… and signed as authorised

…………………………….. Prof. Richard Sullivan

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation AUDITOR’S REPORT TO THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2020

We have audited the financial statements of The ecancer Global Foundation for the year ended 31 December 2020 which comprise the Statement of Financial Activities, the Balance Sheet and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Opinion on financial statements

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

Other information

The other information comprises the information included in the annual report, other than the financial statement and our auditor’s report thereon. The trustees are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation AUDITOR’S REPORT TO THE TRUSTEES (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Charities Act 2011 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional

scepticism throughout the audit. We also:

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation AUDITOR’S REPORT TO THE TRUSTEES (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020

Extent to which the audit was considered capable of detecting irregularities, including fraud

Owing to the inherent limitations of an audit, there is an unavoidable risk that material misstatements in the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISA’s (UK).

In identifying and assessing risks of material mis-statement in respect of fraud, including irregularities and noncompliance with laws and regulations, our procedures included the following:

• We obtained an understanding of the legal and regulatory frameworks applicable to the company financial statements or that had a fundamental effect on the company’s operations. We determined that the most significant laws and regulations included UK GAAP, UK Companies Act 2006 and taxation laws.

• We understood how the company is complying with those legal and regulatory frameworks by making inquiries of management, those responsible for legal and compliance procedures.

• We assessed the susceptibility of the company’s financial statements to material misstatement, including how fraud might occur. Audit procedures performed by the engagement team included:

• Identifying and assessing the design effectiveness of controls management has in place to prevent and detect fraud;

• Understanding how those charged with governance considered and addressed the potential for override of controls or other inappropriate influence over the financial reporting process. Detailed analysis of journals posted through the accounting system during the year to 31 December 2020 has been undertaken;

• Understanding the controls in place to prevent and detect fraud. Reliance was not placed on controls for the entirety of the audit, instead taking a substantive testing approach, however controls were in place to prevent fraud, and they appeared to be working effectively;

• Challenging assumptions and judgements made by management in its significant accounting estimates.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with the Charities Act 2011. Our audit work has been undertaken so that we might state to the trustees those matters we are required to state to them in an auditors’ report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

……………………… Martin Howard (Senior Statutory Auditor) For and on behalf of Hazlewoods LLP, Statutory Auditor

Windsor House Bayshill Road Cheltenham GL50 3AT

19/10/2021

Date: …………………

Hazlewoods LLP are eligible to act as auditors in terms of section 1212 of the Companies Act 2006.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The e cancer Global Foundation STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2020

INCOMING
RESOURCES
Unrestricted
funds
Notes
Donations and
legacies
Charitable
Activities
E-learning
Events
Journal
Research
projects
Educational
video
Other Activities
to Generate
Funds
Advertising
income
Total Incoming
Resources
Resources
Expended
Raising funds
Charitable
Expenditure
E-learning
Events
Journal
Research
projects
Educational
videos
Total
Resources
Expended
2
Net movements
in funds
Transfer
between funds
Total funds
brought
forward
Balance carried
forward at 31
December 2020		 Unrestricted
funds
2020
£
1,185
13,196
23,172
20,346
-
341,512
71,178
470,589
-
9,327
97,820
72,550
-
120,097
299,794
299,794
170,795
56,205
(183,797)
43,205		 Restricted
funds
2020
£
-
93,360
42,008
-
41,144
383,644
-
560,156
-
93,360
42,008
-
35,643
373,331
544,342
544,342
15,814
(56,205)
56,206
15,813		 Total funds
2020
£
1,185
106,556
65,180
20,346
41,144
725,156
71,178
1,030,745
-
102,686
139,828
72,550
35,643
493,428
844,136
844,136
186,609
-
(127,591)
59,018		 Total funds
2019
£
1,531
95,935
57,243
3,915
51,837
700,860
28,310
939,631
11,049
94,870
148,947
87,136
41,628
732,050
1,104,631
1,115,680
(176,047)
-
48,454
(127,591)

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation BALANCE SHEET AT 31 DECEMBER 2020

Note
Fixed assets
3,7
Current Assets
Debtors and prepayments
4,7
Cash at bank and in hand
Less Creditors: Amounts
falling due within one year
5,7
Net Current Assets
Net Assets
Represented by:
Unrestricted funds:
6
Restricted funds
6		 2020
2,063
145,770
158,515
304,285
(247,330)
56,955
59,018
43,205
15,813
59,018		 2019
£
1,210
258,076
10,202
268,278
(397,079)
(128,801)
(127,591)
(183,797)
56,206
(127,591)

18/10/2021

Approved by the trustees on ………………. and signed on their behalf by:

………………….. Prof R Sullivan

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2020

2020
2019
£
£
Cash flows from operating activities

Surplus for the year
186,609
(224,501)
Adjustments to cash flows from non-cash items
Depreciation and amortisation 374
119
186,983
(224,382)
Working capital adjustments
(Increase)/decrease in debtors 112,306
(178,663)
(Decrease)/increase in creditors (149,749)
148,946
Cash generated from operations
149,540
(254,099)
Net cash flow from operatingactivities
149,540
(254,099)
Cash flows from investing activities
Acquisitions of tangible assets (1,227)
(1,329)
Proceeds from sale of tangible assets -
-
Net cash flows from investingactivities
(1,227)
(1,329)
Cash flows from financing activities
Net cash flows from financingactivities
-
-
Net (decrease)/increase in cash and cash equivalents
148,313
(206,972)
Cash and cash equivalents at 1 January
10,202
217,174
Cash and cash equivalents at 31 December
158,515
10,202

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The e cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

1. Accounting Policies

Basis of Preparation

The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain fixed assets, adopting the following principal accounting policies all of which are in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Charities Act 2011.

General information

The financial statements are presented in Pounds Sterling. The charity is a public benefit charitable incorporated organisation, incorporated in England and Wales.

The address of its registered office is: 13 King Square Avenue Bristol BS2 8HU

Judgements and estimation uncertainty

The trustees consider that there are no key areas of judgement or estimation uncertainty to be disclosed in these financial statements.

Tangible fixed assets and depreciation

Tangible fixed assets are stated in the accounts at cost or revalued amount less depreciation. Depreciation is provided at rates calculated to write off the cost of each asset over its expected useful life.

Depreciation is provided to write off the cost/value of assets over their useful lives as follows:

Office equipment 5 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade receivables

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All debtors are repayable within one year and are hence included at the undiscounted amount of the cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the Charity will not be able to collect all amounts due according to the original terms of the receivables.

Trade payables

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the Charity does not have an unconditional right, at the end of the reporting year, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

Legacies, Donations and Grants Receivable

All income is recognised when receivable and when capable of financial measurement. Receipts of property investments or other gifts in king are included at market value.

Going concern

There are no significant factors affecting the charity’s ability to continue as a going concern.

Expenditure on Charitable activities

Expenditure on Charitable activities is included in the Statement of Financial Activities on an accruals basis. Where expenditure is directly attributable to more than one activity, it is apportioned across cost categories on the basis of the proportion of income receivable relating to each activity.

Funds

Funds held by the charity are either:

Pensions

The company operates a defined contribution scheme for certain employees. The contributions are charged to revenue in the year in which they are incurred.

2. Analysis of Total Resources Expended

Charitable Expenditure
E-learning
Events
Journal
Research projects
Educational videos		 Direct
Activities
£
-
-
105,348
-
84,995
190,343		 Grant
funding
£
112,457
134,035
-
37,631
258,011
542,134		 Support
costs
(see 2a
below) £
9,063
11,361
18,534
5,049
68,097
112,104		 2020
2019
Total
£
Total
£
121,519
94,870
145,396
148,946
123,882
87,136
42,680
41,628
411,103
732,050
844,581
1,104,631

Support costs are allocated on the basis of full-time equivalents.

Staff costs:
Wages and salaries
Social security costs
Pension costs
The average number of full time employees
In the period was		 2020
£
451,355
37,347
35,670
524,372
Number
17		 2019
£
499,410
32,867
47,502
579,779
Number
21

No employee earned £60,000 or more, and no Trustees were remunerated through the charity.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The ecancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

2a. Analysis of Support Costs

Raising funds
E-learning
Events
Journal
Research projects
Educational videos		 2020
£
-
9,063
11,361
18,534
5,049
68,097
112,104		 2019
£
11,049
11,853
14,859
24,241
6,604
89,064
157,670

Support costs are all allocated to charitable expenditure, other than £nil (2019 - £11,049) incurred in relation to raising funds within the year.

Auditors remuneration accrued during the year was £6,000 (2019 - £2,100 as independent examination fees due to no audit being undertaken). No other services were provided by the auditors.

3. Fixed assets

Cost
At 1 January 2020
Additions
December 31, 2020
Depreciation
At 1 January 2020
Charge for the year
December 31, 2020
Net book value
December 31, 2020
December 31, 2019
4.
Debtors
Trade debtors
Other debtors
Prepayments and accrued income		 Office
equipment
£
1,329
1,227
2,556
119
374
493
2,063
1,210
2020
£
64,483
-
81,287
145,770		 Total
£
1,329
1,227
2,556
119
374
493
2,063
1,210
2019
£
145,313
39
112,724
258,076

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The e cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

5. Creditors: Amounts falling due within one year

Trade creditors
Taxation and social security
Accruals and deferred income
Other creditors		 2020
£
23,516
10,391
207,818
5,605
247,329		 2019
£
149,599
10,635
228,013
8,832
397,079

Included within accruals and deferred income is £199,718 (2019 - £221,897) in relation to income deferred on performance-related grants. These grants are considered to contain conditions that require the charity to undertaken certain activities before it becomes fully entitled to the respective grant monies.

Reconciliation of deferred income

At 1 January 2020
Deferred income released
Additional deferred income
At 31 December 2020		 Deferred income
£
221,897
(221,897)
199,718
199,718

6. Funds

General fund
Restricted
fund
E-learning
Events
Journal
Research
Educational
videos
Transfer
between funds		 1 January
2020
£
(183,797)
(7,053)
(17,229)
-
7,036
12,810
60,642
(127,591)		 Incoming
resources
£
470,589
93,360
42,008
-
41,144
383,644
-
1,030,745		 Transfer
between
funds
£
56,206
7,053
17,229
-
(7,036)
(12,810)
(60,642)
-		 Outgoing
resources
£
(299,793)
(93,360)
(42,008)
-
(35,643)
(373,331)
-
(844,136)		 31 December
2020
£
43,205
-
-
-
5,500
10,313
-
59,018

The restricted funds are held separately as they relate to specific performance related grant funds and expenditure. They represent various projects for which the donors have specified the use of the funds. These have been grouped into various categories for the purpose of the note above.

A transfer has been made between the funds to correct amounts incorrectly treated in the prior year, as well as to clear out negative restricted fund balances at year end, and move the deficit back to general funds.

DocuSign Envelope ID: ED684C11-5A0D-4B5B-A79A-C50D357DEBD0

The e cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

7. Reconciliation of funds per asset/liability

Fixed assets
Current assets
Current liabilities
Fixed assets
Current assets
Current liabilities		 Unrestricted
funds
£
2,063
224,884
(47,611)
179,336
Unrestricted
funds
£
1,210
195,741
(175,182)
21,769		 Restricted
funds
£
-
79,400
(199,718)
(120,318)
Restricted
funds
£
-
72,537
(221,897)
(149,360)		 2020
Total
£
2,063
304,284
(247,329)
59,018
2019
Total
£
1,210
268,278
397,079
(127,591)

8. Related party transactions

The charity has no related party transactions to disclose.